{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Curculigo orchioides", "acrolein", "antioxidant", "cyclophosphamide", "pro-inflammatory cytokines"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26424815", "DateCompleted": {"Year": "2017", "Month": "10", "Day": "12"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "09", "Day": "29"}], "ELocationID": ["10.1177/1534735415607319"], "Language": ["eng"], "Journal": {"ISSN": "1552-695X", "JournalIssue": {"Volume": "15", "Issue": "2", "PubDate": {"Year": "2016", "Month": "Jun"}}, "Title": "Integrative cancer therapies", "ISOAbbreviation": "Integr Cancer Ther"}, "ArticleTitle": "Curculigo orchioides Gaertn Effectively Ameliorates the Uro- and Nephrotoxicities Induced by Cyclophosphamide Administration in Experimental Animals.", "Pagination": {"StartPage": "205", "EndPage": "215", "MedlinePgn": "205-15"}, "Abstract": {"AbstractText": ["Background Curculigo orchioides Gaertn is an ancient medicinal plant (Family: Amaryllidaceae), well known for its immunomodulatory and rejuvenating effects. Cyclophosphamide (CPA) is an alkylating agent widely used for treating a variety of human malignancies, but associated with different toxicities too. Our previous reports regarding the hemoprotective and hepatoprotective effects of the plant against CPA toxicities provide the background for the present study, which is designed to analyze the ameliorative effect of the methanolic extract of C orchioides on the urotoxicity and nephrotoxicity induced by CPA. Methods CPA was administered to male Swiss albino mice at a single dose of 1.5 mmol/kg body weight to induce urotoxicity after 5 days of prophylactic treatment with C orchioides extract (20 mg/kg body weight). Mesna (2-mercaptoethanesulfonate) was used as a control drug. Serum, tissue, and urine levels of kidney function markers and antioxidant levels were checked along with the serum cytokine levels. Results The plant extract was found to be effective in ameliorating the urotoxic and nephrotoxic side effects of CPA. Upregulation of serum interferon-\u03b3 and interleukin-2 levels were observed with C orchioides treatment, which was decreased by CPA administration. Besides these, serum tumor necrosis factor-\u03b1 level was also downregulated by C orchioides treatment. Conclusion Curculigo orchioides was found to be effective against the CPA-induced bladder and renal toxicities by its antioxidant capability and also by regulating the pro-inflammatory cytokine levels."], "CopyrightInformation": "\u00a9 The Author(s) 2015."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amala Cancer Research Centre, Affiliated to the University of Calicut, Thrissur, Kerala, India."}], "LastName": "Murali", "ForeName": "Vishnu Priya", "Initials": "VP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amala Cancer Research Centre, Affiliated to the University of Calicut, Thrissur, Kerala, India immunologyacrc@gmail.com."}], "LastName": "Kuttan", "ForeName": "Girija", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Integr Cancer Ther", "NlmUniqueID": "101128834", "ISSNLinking": "1534-7354"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "82115-62-6", "NameOfSubstance": "Interferon-gamma"}, {"RegistryNumber": "8N3DW7272P", "NameOfSubstance": "Cyclophosphamide"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["chemistry"], "DescriptorName": "Curculigo"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Cyclophosphamide"}, {"QualifierName": ["drug therapy", "etiology"], "DescriptorName": "Drug-Related Side Effects and Adverse Reactions"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interferon-gamma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-2"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Models, Animal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": ["drug effects"], "DescriptorName": "Up-Regulation"}], "CoiStatement": "<b>Declaration of Conflicting Interests:</b> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ayash LJ, Wright JE, Tretyakov O, et al. Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol. 1992;10:995-1000.", "ArticleIdList": ["1588381"]}, {"Citation": "Gibbons RB, Westerman E. Acute non-lymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis. Arthritis Rheum. 1988;31:1552-1554.", "ArticleIdList": ["3196367"]}, {"Citation": "Ortiz A, Gonzalez-Parra E, Aloarez-Costa G, Egido J. Bladder cancer after cyclophosphamide therapy for lupus nephritis. Nephron. 1992;60:378-379.", "ArticleIdList": ["1565199"]}, {"Citation": "Anderson D, Bishop JB, Garner RC, Ostrosky-Wegman P, Selby PB. Cyclophosphamide. Review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res. 1995;330:115-181.", "ArticleIdList": ["7623863"]}, {"Citation": "Schwartz LS, Grindey GB. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immuno-suppression. Cancer Res. 1973;33:1837-1844.", "ArticleIdList": ["4720795"]}, {"Citation": "Zinke H, Woods JE. Donor pretreatment in cadaver renal transplantation. Surg Gynecol Obstet. 1977;145:183-188.", "ArticleIdList": ["327596"]}, {"Citation": "Lares RM, Penner JA. Refractory thrombocytopenic purpura successfully with cyclophosphamide. JAMA. 1971;215:445-449.", "ArticleIdList": ["5107390"]}, {"Citation": "Berrigan MJ, Mannello AJ, Pavelic Z, Williams CJ, Struck RF. The protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism. Cancer Res. 1982;42:3688-3695.", "ArticleIdList": ["6809312"]}, {"Citation": "Cox PJ. Cyclophosphamide cystitis identification of acrolein as the causative agent. Biochem Pharmacol. 1979;28:2045-2049.", "ArticleIdList": ["475846"]}, {"Citation": "Brock V, Stekar J, Poni J. Acrolein, the causative factor of urotoxic side-effects of CYCLOPHOSPHAMIDE, ifosfamide, trofosfamide and sufosfamide. Arneim Forsch. 1979;29:659-661.", "ArticleIdList": ["114192"]}, {"Citation": "Yu LJ, Drewes P, Gustafsson K, Brain EG, Hecht JE, Waxman DJ. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity. J Pharmacol Exp Ther. 1999;288:928-937.", "ArticleIdList": ["10027828"]}, {"Citation": "Mashiach E, Sela S, Weinstein T, Cohen HI, Shasha SM, Kristal B. Mesna: a novel renoprotective antioxidant in ischaemic acute renal failure. Nephrol Dial Transplant. 2001;16:542-551.", "ArticleIdList": ["11239029"]}, {"Citation": "Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol. 1999;17:3333-3355.", "ArticleIdList": ["10506637"]}, {"Citation": "Jalali AL, Hassanzadeh S, Malekinejad H. Chemoprotective effect of Crataegus monogyna aqueous extract against cyclophosphamide-induced reproductive toxicity. Vet Res Forum. 2011;2:266-273."}, {"Citation": "Irshad S, Singh J, Jain SP, Khanuja SPS. Curculigo orchioides Gaertn. (Kali musali) an endangered medicinal plant of commercial value. Nat Prod Radiance. 2006;5:369-372."}, {"Citation": "Ma C, Zhang J, Fu J, Cheng L, Zhao G, Gu Y. Up-regulation of VEGF by MC3T3-E1 cells treated with curculigoside. Phytother Res. 2011;25:922-926.", "ArticleIdList": ["21394809"]}, {"Citation": "Lakshmi V, Pandey K, Puri A, Saxena RP, Saxena KC. Immunostimulant principles from Curculigo orchiodes. J Ethnopharmacol. 2003;89:181-184.", "ArticleIdList": ["14611880"]}, {"Citation": "Rathod BD, Lahiri S, Yadav KG, Shah BM. Immunomodulatoroy and antioxidant activity of Curculigo orchiodes Gaertn. Int J Pharm Tech Res. 2010;2:1197-1203."}, {"Citation": "Singh R, Gupta AK. Antimicrobial and antitumor activity of the fractionated extracts of Kalimusli (Curculigo orchiodes). Intl J Green Pharm. 2008;2:34-36."}, {"Citation": "Venkatesh P, Mukharjaee PK, Kumar SN, et al. Mast cells stabilization and antihistamic potentials of Curculigo orchiodes rhizomes. J Ethnopharmacol. 2009;126:434-436.", "ArticleIdList": ["19781614"]}, {"Citation": "Jiao L, Cao DP, Qin LP, et al. Antiosteoporotic activity of phenolic compounds from Curculigo orchioides. Phytomedicine. 2009;16:874-881.", "ArticleIdList": ["19328665"]}, {"Citation": "Murali VP, Kuttan G. Enhancement of cancer chemotherapeutic efficacy of cyclophosphamide by Curculigo orchioides Gaertn. and its ameliorative effects on cyclophosphamide-induced oxidative stress. Integr Cancer Ther. 2015;14:172-183.", "ArticleIdList": ["25575532"]}, {"Citation": "Wood R, Eichel L, Messing EM, Schwarz E. Automated noninvasive measurement of cyclophosphamide-induced changes in murine micturition frequency and volume and demonstration of pharmacologic sensitivity. Urology. 2001;57:115-116.", "ArticleIdList": ["11378091"]}, {"Citation": "Verley H, Gowenlock HA, Bell M. Practical Clinical Biochemistry. 5th ed. London, England: William Hieneman Medical Books; 1980:550-555."}, {"Citation": "Wybenga DR, Giorgio JD, Pileggi VJ. Manual and automated methods for urea nitrogen measurement in whole serum. Clin Chem. 1971;17:891-895.", "ArticleIdList": ["5571487"]}, {"Citation": "Ohkawa H, Oshishi N, Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.", "ArticleIdList": ["36810"]}, {"Citation": "Moron MA, Depierre JW, Mannervick B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979;582:67-78.", "ArticleIdList": ["760819"]}, {"Citation": "McCord JM, Fridovich I. Superoxide dismutase, an enzymatic function for erythrocuprein. J Biol Chem. 1969;244:6049-6055.", "ArticleIdList": ["5389100"]}, {"Citation": "Hafemann DG, Sunde RA, Houestra WG. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr. 1974;104:580-584.", "ArticleIdList": ["4823943"]}, {"Citation": "Aebi H. Catalase estimation. In: Berg Meyer HV, ed. Methods of Enzymatic Analysis. New York, NY: Verlag Chemie; 1974:673-668."}, {"Citation": "Davis L, Kuttan G. Effect of Withania somnifera on cyclophosphamide-induced urotoxicity. Cancer Lett. 2000;148:9-17.", "ArticleIdList": ["10680587"]}, {"Citation": "Bishel MD. Cyclophosphamide\u2014hemorrhagic cystitis following prolonged low dose therapy. JAMA. 1979;20:238-239.", "ArticleIdList": ["448907"]}, {"Citation": "Javadpour N, Burakat HA. Bladder toxicity due to cyclophosphamide. Experimental induction and treatment. Urology. 1973;2:634-636.", "ArticleIdList": ["4203163"]}, {"Citation": "Donelli MG, Gerratini S. Drug metabolism after repeated treatments with cytotoxic agents. Eur J Cancer. 1971;7:361-364.", "ArticleIdList": ["5570713"]}, {"Citation": "Girtoo HL, Hipkins JH, Sharma SD. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res. 1981;41:3584-3591.", "ArticleIdList": ["7260917"]}, {"Citation": "Atessahin A, Karahan I, Yilmaz S, Ceribasi AO, Pirincci I. The effect of manganese chloride on gentamicine-induced nephrotoxicity in rats. Pharmacol Res. 2003;48:637-642.", "ArticleIdList": ["14527830"]}, {"Citation": "Cagler K, Kinalp C, Arpaci F, et al. Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem cell transplantation. Nephrol Dial Transplant. 2002;17:1931-1935.", "ArticleIdList": ["12401849"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "9", "Day": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26424815", "PMC5736055", "10.1177/1534735415607319", "1534735415607319"]}}], "PubmedBookArticle": []}